Jabak Signed A Memorandum Of Understanding With The Red Cross Concerning The Prosthetics And Orthoti

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AA33	ENTYVIO	BioTech	Vedolizumab - 108mg	108mg	Injectable solution	88,955,869 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
B05CX01	DEXTROSE 20% INJECTION USP	G	Glucose - 20%	20%	Injectable solution	316,025 L.L
L04AA33	ENTYVIO	BioTech	Vedolizumab - 108mg	108mg	Injectable solution	88,955,869 L.L
B05CX01	DEXTROSE 20% INJECTION USP	G	Glucose - 20%	20%	Injectable solution	183,869 L.L
C03CA01	FRURETIC	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	2,600,655 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
C03CA01	FUROLIX	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	1,612,611 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	451,531 L.L
N05AF05	CLOPIXOL DEPOT	B	Zuclopenthixol decanoate - 200mg/ml	200mg/ml	Injectable solution	512,004 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	159,736 L.L
C03CA01	FUROSEMIDE SALF	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	216,359 L.L
N05AF05	CLOPIXOL ACUPHASE	B	Zuclopenthixol acetate - 100mg/2ml	100mg/2ml	Injectable solution	857,372 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	179,272 L.L
C03CA01	URO-CARE	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	1,630,081 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	1,791,342 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	191,913 L.L
C03CA01	FUROSEMIDE S.A.L.F.	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	919,188 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	208,002 L.L
L04AA52	KESIMPTA	BioTech	Ofatumumab - 20mg/0.4ml	20mg/0.4ml	Injectable solution	96,542,598 L.L
N05AX12	ABILIFY MAINTENA	B	Aripiprazole - 400mg	400mg	Injectable powder for suspension, prolonged release+solvent	29,491,998 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	36,504,302 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	54,757,132 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
L02AE04	GONAPEPTYL CR	B	Triptorelin - 3.75mg	3.75mg	Injectable powder for suspension+diluent	12,095,730 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	L.L

جبق وقع مذكرة تفاهم مع الصليب الاحمر تختص بالأطراف الإصطناعية والتقويم